Orbit Baby Partners with Emplifi to Provide Immersive Shopping Experience
Using live commerce solution provided by Emplifi, parents-to-be can connect with Orbit Baby product experts…
Using live commerce solution provided by Emplifi, parents-to-be can connect with Orbit Baby product experts…
The fast-growing Texas-based medtech startup names industry vets Trey Swain as CFO and Matthew Cerullo…
The company has grown its customer base by 3.5x, including new customers like Pipe and…
TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries…
BOSTON–(BUSINESS WIRE)–Applause, the world leader in testing and digital quality, recently conducted a survey with…
Wincast is the first platform to enable fans to own iconic moments in sports history…
SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
Prof. Schroeder to advise on SCI-160 formulation development to enhance biological effect and extended effect…
– CEO Remi Barbier to Discuss Q1 2022 Clinical and Corporate Updates – – Stakeholders…
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s…
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Silo Pharma Inc. (OTCQB:…
Exclusive License with Asahi Kasei Pharma to develop and commercialize Apraglutide in Japan includes $30…
Results anticipated in H2 2022 NEWTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics…
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
STOUGHTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced…
The Company also Plans on Sharing INKmune™ Patient Case Studies Boca Raton, Florida, March 30,…
Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
WALTHAM, Mass., March 30, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
BOSTON, March 30, 2022 (GLOBE NEWSWIRE) — PepGen, Inc., advancing the next generation of oligonucleotide…
VYN201 demonstrated statistically significant improvement in treatment response for both endpoints at 1mg/kg and 10mg/kg doses…